ATG12 Antibody

What is the molecular weight of ATG12 that should be detected in Western blots?

While the calculated molecular weight of free ATG12 is approximately 15 kDa, researchers typically observe bands at 48-55 kDa in Western blots . This represents the functional ATG12-ATG5 conjugate rather than free ATG12. Some antibodies can detect both free ATG12 and the ATG12-ATG5 conjugate, though the free form is often not observed in many cell types under normal conditions .

Which applications are ATG12 antibodies commonly used for in research?

ATG12 antibodies are validated for multiple applications including:

• Western Blotting (WB): Typically used at 1:500-1:1000 dilution

• Immunohistochemistry (IHC): Used at 1:20-1:200 or 1:50-1:500 dilution

• Immunofluorescence (IF): Used at 1:200-1:800 dilution

• Immunoprecipitation (IP): Typically requires 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate

• Enzyme-Linked Immunosorbent Assay (ELISA)

How should samples be prepared for optimal ATG12 detection in Western blotting?

For optimal ATG12 detection in Western blots, samples should be run under reducing conditions on SDS-PAGE gels. Lysates/proteins are typically loaded at 20 μg per lane . For the ATG12-ATG5 conjugate detection, membranes can be probed with anti-ATG12 antibody (typically at 1:500 dilution) followed by an appropriate HRP-conjugated secondary antibody. Using a loading control such as alpha-tubulin is recommended to normalize protein levels across samples . Some protocols specifically recommend Immunoblot Buffer Group 2 for optimal results when detecting the ATG5-ATG12 heterodimer .

What cell lines are recommended as positive controls for ATG12 antibody validation?

Based on the antibody validation data, the following cell lines have shown positive detection of ATG12 and can be used as controls:

• HeLa (human cervical epithelial carcinoma)

• THP-1 (human monocytic leukemia)

• HCT-116 (human colorectal carcinoma)

• PC-3 (human prostate cancer)

• COLO 320 (human colorectal adenocarcinoma)

• NIH/3T3 (mouse fibroblast)

• C2C12 (mouse myoblast)

• RAW 264.7 (mouse monocyte/macrophage)

Why are ATG12 knockout cell lines important in antibody validation?

ATG12 knockout cell lines, such as the ATG12 knockout THP-1 cell line (ab277831), are critical for confirming antibody specificity . When running Western blots with both wild-type and knockout samples, a specific band at approximately 52 kDa (representing the ATG12-ATG5 complex) should be present in wild-type lysates but absent in ATG12 knockout lysates. This validation method ensures that the observed bands are truly ATG12-specific and not a result of non-specific binding .

Why does the observed band size for ATG12 differ from the predicted molecular weight?

The predicted molecular weight of free ATG12 is approximately 15 kDa, but researchers typically observe bands at 48-55 kDa. This discrepancy occurs because ATG12 is predominantly found conjugated to ATG5, forming a heterodimer of approximately 52 kDa . Free (unconjugated) ATG12 is often not observed at 15 kDa in many cell types under normal conditions. Some antibodies, like ab155589, are designed to detect both free ATG12 and ATG12 conjugated to ATG5, though the conjugated form is more commonly detected .

What strategies can resolve weak or absent ATG12 signals in Western blotting?

If experiencing weak or absent ATG12 signals, consider these approaches:

• Optimize antibody concentration (try a range from 1:200 to 1:1000)

• Ensure protein loading is sufficient (minimum 20 μg per lane)

• Use gentle sample preparation methods to preserve the ATG12-ATG5 complex

• Consider inducing autophagy in cells (e.g., with starvation or rapamycin) to increase ATG12-ATG5 conjugate levels

• Verify the antibody specificity for your species of interest (most are validated for human and mouse samples)

• Implement enhanced chemiluminescence techniques for higher sensitivity

• Consider using a fresh lot of antibody if the current one has undergone multiple freeze-thaw cycles

What are recommended antigen retrieval methods for ATG12 immunohistochemistry?

For optimal ATG12 detection in immunohistochemistry applications:

• Primary recommendation: TE buffer at pH 9.0 for antigen retrieval

• Alternative method: Citrate buffer at pH 6.0

• Antibody dilutions typically range from 1:20-1:200 or 1:50-1:500 depending on the specific antibody

• Testing both methods with your specific tissue samples is advisable for determining optimal conditions

How can ATG12 antibodies be used to investigate the ATG12-ATG5 conjugation process?

To investigate the ATG12-ATG5 conjugation process, researchers can:

• Perform co-immunoprecipitation (Co-IP) using ATG12 antibodies to pull down the ATG12-ATG5 complex and associated proteins

• Use Western blotting with both ATG12 and ATG5 antibodies on the same samples to compare expression patterns

• Conduct immunofluorescence studies to examine co-localization of ATG12 with ATG5 in autophagosomes

• Test the effects of genetic manipulation (knockdown/knockout) of ATG7 or ATG10 on ATG12-ATG5 conjugation levels

• Monitor the ATG12-ATG5 conjugate formation under various autophagy-inducing conditions (e.g., starvation, rapamycin treatment)

What is the significance of the ATG12-interacting motif (AIM12) in autophagy research?

The ATG12-interacting motif (AIM12), consisting of an aspartic acid (Asp)-methionine (Met) sequence, mediates the interaction between ATG12 and ATG3 . This motif is crucial for:

• E2-E3 interaction during ATG8 lipidation, a critical step in autophagosome formation

• ATG12's recognition of ATG3 via a hydrophobic pocket and a basic residue

• The functional conjugation process essential for autophagy regulation

Understanding the AIM12 provides structural insights that could lead to the development of chemicals that regulate autophagy by targeting ATG12-family proteins. The conservation of this motif across species (from plants to humans) highlights its evolutionary importance in autophagy mechanisms .

How can ATG12 antibodies be used to study autophagy flux in cells?

To study autophagy flux using ATG12 antibodies:

• Monitor changes in ATG12-ATG5 conjugate levels under basal conditions versus autophagy induction (e.g., starvation, rapamycin)

• Combine with other autophagy markers like LC3-II and p62 for comprehensive flux analysis

• Use immunofluorescence to visualize autophagosome formation, particularly in response to stimuli like LPS (as demonstrated in RAW 264.7 cells)

• Perform time-course experiments with autophagy inducers and inhibitors (like bafilomycin A1) to distinguish between increased autophagosome formation and decreased clearance

• Compare ATG12 staining patterns in normal versus stressed conditions (e.g., UV-treated HEK-293 cells show altered ATG12 expression patterns)

What experimental designs can distinguish between different ATG12 isoforms or complexes?

To distinguish between different ATG12 isoforms or complexes:

How can ATG12 antibodies be optimized for detecting autophagy events across diverse tissue types?

Optimizing ATG12 antibodies for diverse tissue types requires:

• Antibody titration to determine optimal concentration for each tissue (typically ranging from 1:20-1:500 for IHC)

• Tissue-specific antigen retrieval methods (TE buffer pH 9.0 or citrate buffer pH 6.0)

• Validation using positive control tissues (human bladder tissue, prostate cancer tissue, and colon cancer tissue have shown good reactivity)

• Counterstaining with other autophagy markers for confirmatory analysis

• Species-specific considerations: most antibodies are validated for human and mouse samples, but some show cross-reactivity with rat, pig, and hamster samples

• For fluorescence detection, appropriate secondary antibodies (e.g., NorthernLights™ 557-conjugated Anti-Mouse IgG) and DAPI counterstaining for nuclei visualization

What methodological approaches can resolve contradictory data in ATG12 autophagy research?

When facing contradictory data in ATG12 research, consider these methodological approaches:

• Antibody validation using knockout controls to ensure specificity:

  • Compare results with multiple antibodies targeting different epitopes of ATG12

  • Include ATG12 knockout samples (e.g., ATG12 knockout THP-1 cell lysate)

• Comprehensive experimental design:

  • Parallel analysis of multiple autophagy markers (ATG12-ATG5, LC3-I/II, p62)

  • Time-course experiments to capture the dynamic nature of autophagy

  • Combined approaches (WB, IF, EM) to provide multiple lines of evidence

• Context consideration:

  • Cell-type specific differences in autophagy regulation

  • Impact of culture conditions on basal autophagy levels

  • Developmental stage or disease state effects on ATG12 expression patterns

• Technical validation:

  • Repeat experiments with standardized protocols across different labs

  • Use quantitative approaches with appropriate statistical analysis

  • Address potential technical artifacts through methodological controls

By implementing these structured approaches, researchers can more effectively resolve contradictory data and advance our understanding of ATG12's role in autophagy.